http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4121001-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
| filingDate | 1991-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1993-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-4121001-C1 |
| abstract | The invention concerns pyrimidine and purine nucleosides intended for use against infections caused by adenoviruses. |
| priorityDate | 1991-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.